Vernal Biosciences

United States
Dunmore, Pennsylvania, United States

Company profile

Vernal Biosciences company profile

Vernal Biosciences specializes in high-purity mRNA for research and clinical use. Its platform processes and analytical methods will remove the guesswork and lengthy development cycles inherent to many manufacturing processes in the advanced therapeutics field. Its high-purity supply and services provide the flexibility to perform proper drug discovery and development without risking the buildout of costly teams and facilities.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2021-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$41M
Last funding
Series A / $20M / 2023-06-27
Last equity funding
Series A / $20M
Investors
6
Lead investors
4
Founders
1
Articles
20

Founders and investors

Founders

Christian Cobaugh

Lead investors

Alloy TherapeuticsAmpersand Capital PartnersCharles River Laboratories InternationalDynamk Capital

Investors

Alloy TherapeuticsAmpersand Capital PartnersCharles River Laboratories InternationalDynamk CapitalVermont Center for Emerging Technologies